Please assess the completion status of the following clinical trial:

Trial Title: Comparison of Aerosol Delivery of Infasurf to Usual Care in Spontaneously Breathing RDS Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~RDS Patients~1. NICU patient, ≥1hour of age and \<24 hours of age.~2. Clinical diagnosis of RDS, with or without chest X-ray data.~3. Inspired oxygen ≥21% to maintain adequate oxygen saturation.~4. Not intubated~5. Requiring:~   1. nasal continuous positive airway pressure (nCPAP).~Exclusion Criteria:~1. Congenital anomaly limiting care options or requiring early surgery.~2. Cardiopulmonary decompensation.~   1. hypotension with metabolic acidosis (base excess \< -10 meq/l).~  2. Oxygen saturations \< 88% at start of aerosolization.~  3. PaCO2 ≥ 60 mmHg at start of aerosolization.~3. Grade 3 or Grade 4 intraventricular hemorrhage by cranial ultrasound, if known.~4. Acute hypoxic encephalopathy with or without seizures.

- Gender: ALL
- Minimum Age: 1 Hour
- Maximum Age: 24 Hours
- Healthy Volunteers: f

Study Arms:
- Aerosolized Calfactant (Type: EXPERIMENTAL): 1. NICU Patients with a clinical diagnosis of RDS~2. Inspired oxygen ≥21% to maintain adequate oxygen saturation~3. Not Intubated~4. Requiring Nasal continuous positive airway pressure
- Usual Care (Type: NO_INTERVENTION): There will be no protocol driven interventions in the usual care group.

Based on this trial design, predict the completion outcome and termination type (if applicable).